Insulet Corp Stock Ownership - Who owns Insulet?

Insider buying vs selling

Have Insulet Corp insiders been buying or selling?
Mark N. FieldSVP Chief Technology Officer2024-06-141,500$199.96
Timothy J. ScannellDirector2024-06-107,000$190.51
Mark N. FieldSVP Chief Technology Officer2024-06-102,131$190.43
Luciana BorioDirector2024-06-04360$182.58
James HollingsheadPresident and CEO2024-05-313,973$177.19
Timothy J. ScannellDirector2024-05-285,525$27.37
Timothy J. ScannellDirector2024-05-285,235$28.87
Timothy J. ScannellDirector2024-05-283,300$180.90
Timothy J. ScannellDirector2024-05-283,587$40.60
Timothy J. ScannellDirector2024-05-283,920$36.38

1 of 4

PODD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PODD insiders and whales buy or sell their stock.

PODD Shareholders

What type of owners hold Insulet Corp stock?
Vanguard Group Inc11.71%8,199,114$1.67BInstitution
Capital Research Global Investors10.80%7,562,093$1.54BInstitution
Blackrock Inc8.60%6,025,770$1.23BInstitution
Fmr LLC7.71%5,402,893$1.10BInstitution
State Street Corp4.17%2,919,169$595.80MInstitution
Pequot Capital Management Inc3.05%2,134,289$435.61MInsider
Samuel D. Colella3.04%2,127,943$434.31MInsider
Versant Venture Capital I LP3.04%2,127,943$434.31MInsider
Wellington Management Group LLP2.84%1,990,242$406.21MInstitution
Citadel Advisors LLC2.38%1,668,492$340.54MInstitution

1 of 3

PODD vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PODD79.69%20.31%Net SellingNet Buying
ALGN84.62%15.38%Net Selling
BRKR49.31%50.69%Net Buying
GMED78.22%21.78%Net SellingNet Selling

Insulet Stock Ownership FAQ

Who owns Insulet?

Insulet (NASDAQ: PODD) is owned by 98.21% institutional shareholders, 25.03% Insulet insiders, and 0.00% retail investors. Pequot Capital Management Inc is the largest individual Insulet shareholder, owning 2.13M shares representing 3.05% of the company. Pequot Capital Management Inc's Insulet shares are currently valued at $435.27M.

If you're new to stock investing, here's how to buy Insulet stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.